510(k) K161297
K161297 is an FDA 510(k) premarket notification submitted by Beckman Coulter Ireland, Inc. for the device "Beta-2-Microglobulin". The FDA issued a decision of Substantially Equivalent on June 7, 2016. The device falls under product code JZG (System, Test, Beta-2-Microglobulin Immunological), a Class II device regulated under 21 CFR 866.5630. Beckman Coulter Ireland, Inc. has at least 6 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 7, 2016
- Date Received
- May 9, 2016
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Beta-2-Microglobulin Immunological
- Device Class
- Class II
- Regulation Number
- 866.5630
- Review Panel
- IM
- Submission Type